HPV and Male Homosexuality in General Practice?

NCT05078554 | Completed

• 1 other identifier: 8048
• Study Type: observational
• Target: 15
• Locations: 1 country
• Sites: 1

Brief Summary

The main objective of this study is to find out whether young MSM (men who have sex with men) believe it is important for their GP to be informed of their sexual orientation, in order to improve their clinical, especially with HPV vaccination. The secondary objective is to analyze the state of knowledge about the HPV vaccine and the value of HPV vaccine in this target population.

Conditions

Papilloma Viral Infection

Keywords

Papilloma Viral Infection; HPV; HPV vaccine

Outcome Measures

Primary Outcomes (1)

• Retrospective descriptive study of vaccination against HPV (Human Papilloma Virus) in Alsace?

  Files analysed retrospectively from April 27, 2021 to January 27, 2020 will be examined]

Eligibility Criteria

• Age: 18 Years - 26 Years
• Sex: male
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Subjetc aged between 18-26 years consulting at the HUS Cegidd as part of an STI screening

You may qualify if:

• Age: 18-26 years
• Consultation at the HUS Cegidd as part of an STI screening
• Subject who expressed no opposition to participating in the study

You may not qualify if:

• Refusal of the patient to participate in the study
• Subject who had already benefited from HPV vaccination (at least one dose)
• Inability to give informed consent
• Subject under safeguarde of justice
• Subject under guardianship or under curatorship

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service du Trait d'Union - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location

MeSH Terms

Conditions

Papillomavirus Infections

Condition Hierarchy (Ancestors)

Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Communicable Diseases; Infections; DNA Virus Infections; Virus Diseases; Tumor Virus Infections; Genital Diseases; Urogenital Diseases; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 13, 2021
• First Posted: October 14, 2021
• Study Start: May 27, 2021
• Primary Completion: January 27, 2022
• Study Completion: January 27, 2022
• Last Updated: September 10, 2022

Record last verified: 2021-10

Locations

FR (1)